SynopsisThe new funds will be used to expand across the US and Europe, as the startup looks to change the pharmacovigilance industry’s services-heavy and manually intensive model.Graph AI, an artificial intelligence startup that has developed a safety platform for pharmacovigilance, has raised $13.3 million in a funding round led by Insight Partners, with existing investor Bessemer Venture Partners participating.This comes less than a year after the company raised $3 million from Bessemer, taking its total funding to roughly $16.3 million. Pharmacovigilance is the regulatory process by which pharmaceutical companiesNow Playing
Graph AI funding: Graph AI raises $13.3 million from Insight Partners, Bessemer to scale AI-native patient-safety platform - The Economic Times
The new funds will be used to expand across the US and Europe, as the startup looks to change the pharmacovigilance industry’s services-heavy and manually intensive model.
TL;DRAI
Graph AI secures $13.3M from Insight Partners to scale AI-native pharmacovigilance, bringing total funding to $16.3M. Targets services-heavy manual workflows in pharma, signaling venture focus on AI automation for regulated verticals with high operational-cost baselines.
90 words~1 min read
